<DOC>
	<DOCNO>NCT00462371</DOCNO>
	<brief_summary>Comparison insulin pump treatment multiple daily insulin injection 38 child type 1 diabetes4-16 year old . Outcome metabolic control , quality life , impact disease cost effectiveness . We hypothesise insulin pump treatment would give good metabolic control quality life .</brief_summary>
	<brief_title>Comparison Between Insulin Pump Treatment Multiple Daily Insulin Injections Diabetic Type 1 Children</brief_title>
	<detailed_description>The current standard insulin treatment type 1 diabetes multiple daily insulin injection therapy ( MDII ) . In seventy , continuous subcutaneous insulin infusion ( CSII ) introduce . CSII gain popularity , perhaps technical advance result improved patient comfort . In child five randomise study ( 1-5 ) complete compare MDII CSII . No data gain quality life impact disease . In trial focus quality life next metabolic control . The trial open-labelled , randomised trial . Both efficacy safety data collect . The trial start 14 week run phase , patient start MDII.In follow randomisation phase patient randomise continue MDII CSII.This phase last 14 weeks.In phase thereafter patient use CSII 14 week . The trial conclude 14 week allocate patient preference phase . Patients type 1 diabetic child 4-16 year old poor metabolic control.hypothesis : good metabolic control CSII , good quality life CSII .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type 1 diabetes , Diagnosed presence IA2 , GAD65 islet cell cytoplasmatic auto antibody , Daily insulin adminstration 1 year longer , Random Cpeptide &lt; 200 pMol , Hba1c &gt; 8.0 % and/or history repeat symptomatic hypoglycaemia , Attending regular school Clinical manifest chronic complication , Pregnancy , Comorbidity , Mental retardation , Psychiatric treatment symptom child parent , Insufficient Dutch language capability absence telephone home</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>quality life</keyword>
	<keyword>child diabetes mellitus type 1</keyword>
	<keyword>Continuous subcutaneous insulin infusion ( CSII )</keyword>
	<keyword>metabolic control</keyword>
</DOC>